1800-272-662
Shopping Cart 0
countryflagAU
Login

Atomo Diagnostics Ltd

Healthcare AU AT1

0.036AUD
-0.001(2.70%)

Last update at 2026-03-13T05:10:00Z

Day Range

0.040.04
LowHigh

52 Week Range

0.010.05
LowHigh

Fundamentals

  • Previous Close 0.04
  • Market Cap32.41M
  • Volume407985
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-4.46335M
  • Revenue TTM3.92M
  • Revenue Per Share TTM0.005
  • Gross Profit TTM 1.73M
  • Diluted EPS TTM-0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -4.97093M -6.84780M -9.95763M -5.70685M -6.02121M
Minority interest - - - - -
Net income -4.97093M -6.84780M -9.95763M -5.72232M -6.43454M
Selling general administrative 1.14M 4.06M 4.86M 4.15M 3.82M
Selling and marketing expenses 3.58M 4.47M - - -
Gross profit 1.79M 1.44M 0.67M 4.25M 3.42M
Reconciled depreciation 1.58M 1.66M 1.89M 2.00M 1.32M
Ebit -5.83638M -7.77739M -11.20790M -5.69138M -6.01343M
Ebitda -4.69473M -6.11812M -9.31611M -3.69398M -4.69510M
Depreciation and amortization 1.14M 1.66M 1.89M 2.00M 1.32M
Non operating income net other - - - - -
Operating income -3.81121M -7.16068M -11.20790M -5.69138M -6.01343M
Other operating expenses 7.60M 11.25M 13.75M 20.81M 13.23M
Interest expense 0.02M 0.00952M 0.11M 0.02M 0.00779M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.06M 0.15M 0.01M 0.00546M 0.08M
Net interest income 0.04M 0.14M 0.06M -0.01001M 0.08M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - -0.93910M -0.05912M 0.02M 0.41M
Total revenue 3.79M 4.09M 2.54M 12.34M 6.72M
Total operating expenses 5.60M 8.77M 11.88M 12.72M 9.93M
Cost of revenue 2.00M 2.65M 1.88M 8.09M 3.30M
Total other income expense net -1.15972M -0.62623M 1.19M -0.01547M -0.00779M
Discontinued operations - - - - -
Net income from continuing ops -4.97093M -6.84780M -9.95763M -5.70685M -6.02121M
Net income applicable to common shares -4.97093M -6.84780M -9.95763M -5.70685M -6.02121M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 9.28M 11.38M 16.47M 26.62M 32.24M
Intangible assets 1.64M - 3.30M 3.57M 3.00M
Earning assets - - - - -
Other current assets - - - - -
Total liab 2.30M 1.29M 1.68M 1.81M 2.15M
Total stockholder equity 6.98M 10.08M 14.79M 24.81M 30.09M
Deferred long term liab - - 1.94M 2.20M 2.03M
Other current liab - 0.57M 0.96M 1.00M 1.41M
Common stock - 70.09M 68.04M 68.04M 67.92M
Capital stock 71.84M - 68.04M 68.04M 67.92M
Retained earnings -64.95433M -60.09034M -53.54975M -44.02647M -38.31962M
Other liab - - 0.10M 0.09M 0.02M
Good will - - - - -
Other assets - 0.00000M 1.94M 2.20M 2.03M
Cash 3.22M 3.69M 6.47M 12.97M 17.95M
Cash and equivalents - - - - -
Total current liabilities 2.17M 1.19M 1.49M 1.53M 2.13M
Current deferred revenue - 0.05M 0.19M - -
Net debt - -3.60332M -6.21544M -12.62560M -17.87893M
Short term debt - 0.08M 0.17M 0.16M 0.07M
Short long term debt - - - - -
Short long term debt total - 0.08M 0.25M 0.34M 0.07M
Other stockholder equity - - 0.30M 0.80M 0.49M
Property plant equipment - - 2.74M 3.98M 3.75M
Total current assets 6.56M 7.59M 10.43M 19.07M 25.48M
Long term investments - - - - -
Net tangible assets - - 13.43M 23.44M 27.09M
Short term investments - - - - -
Net receivables 0.63M 2.06M 1.82M 2.68M 4.49M
Long term debt - - - - -
Inventory 1.65M 1.84M 2.14M 3.42M 3.04M
Accounts payable 0.38M 0.48M 0.18M 0.38M 0.65M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 0.09M 0.30M 0.80M 0.49M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 2.07M - - -
Deferred long term asset charges - - - - -
Non current assets total 2.71M 3.79M 6.04M 7.56M 6.76M
Capital lease obligations 0.19M - 0.25M 0.34M 0.07M
Long term debt total - - 0.08M 0.18M 0.00000M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -0.03389M -0.01608M -0.40128M -2.30550M -5.89757M
Change to liabilities - - 0.06M -0.73185M 0.36M
Total cashflows from investing activities -0.03389M -0.01608M -0.40128M -2.30550M -5.89757M
Net borrowings - - -0.17075M -0.04994M -0.11335M
Total cash from financing activities 1.46M 1.87M -0.17075M 0.02M 1.00M
Change to operating activities - - -0.00236M 0.03M 0.03M
Net income -4.97093M -6.84780M -9.95763M -5.72232M -6.02121M
Change in cash -0.46834M -2.78233M -6.49608M -4.98012M -9.15732M
Begin period cash flow 3.69M 6.47M 12.97M 17.95M 27.10M
End period cash flow 3.22M 3.69M 6.47M 12.97M 17.95M
Total cash from operating activities -1.95882M -4.68610M -5.84767M -3.72492M -4.22525M
Issuance of capital stock 1.65M 2.05M - 0.07M 1.11M
Depreciation 1.58M 1.66M 1.44M 2.00M 1.32M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory 0.19M 0.30M 1.28M -0.37715M -1.83257M
Change to account receivables 0.26M -0.57513M 0.82M 1.71M 1.37M
Sale purchase of stock - - 0.00000M 0.07M 1.11M
Other cashflows from financing activities - -0.18271M -0.17075M -0.04994M -0.11335M
Change to netincome - - 0.06M 0.27M 0.55M
Capital expenditures 0.03M 0.02M 0.40M 2.31M 5.90M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.45M -0.27328M 0.07M 0.00546M 0.09M
Stock based compensation 0.03M 0.04M - - -
Other non cash items 0.95M 0.74M - 3.72M 4.70M
Free cash flow -1.99271M -4.70219M -6.24895M -6.03042M -10.12282M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AT1
Atomo Diagnostics Ltd		 -0.001 2.70% 0.04 - 84.75 8.27 4.51 7.74 -1.932
COH
Cochlear Ltd		 -4.74 2.65% 174.42 33.10 26.39 4.88 6.04 5.59 23.13
4DX
4DMEDICAL Ltd		 -0.15 3.55% 4.07 - - 401.92 37.59 417.71 -7.2899
AVR
Anteris Technologies Global Corp		 - -% 9.10 - - 475.96 166.77 334.65 -5.1986
PNV
Polynovo Ltd		 - -% 0.94 94.00 30.21 4.66 7.81 4.68 93.96

Reports Covered

Stock Research & News

View All

Profile

Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers blood test devices, such as Pascal, Curie, Galileo, Elion, and Florey under the AtomoRapid brand. It also offers HIV Rapid self-Test device; and digital health solutions. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.

Atomo Diagnostics Ltd

3-5 George Street, Leichhardt, NSW, Australia, 2040

Key Executives

Name Title Year Born
Mr. John Michael Kelly Founder, CEO, MD & Director NA
Mr. William Edward Souter BCom, LLB (Adel), IPAA Chief Financial Officer NA
Ms. Chandra Sukumar Chief Operating Officer NA
Mr. Jim P. McMenamy Head of Bus. Devel. & Partnerships of the Americas NA
Ms. Anna Tucker Head of Bus. Devel. & Partnerships of Europe, Middle East and Africa NA
Mr. Tharun Kuppanda Company Sec. NA
Mr. Jim P. McMenamy Head of Business Development & Partnerships of the Americas NA
Ms. Anna Tucker Head of Business Development & Partnerships of Europe, Middle East and Africa NA
Ms. Maria Clemente Company Secretary NA
Mr. Jim P. McMenamy Head of Business Development & Partnerships of the Americas NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.